Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 111   

Articles published

JNJ 102.51 -0.29 (-0.28%)
price chart
Johnson & Johnson could bring 700 jobs to Tampa area
TAMPA - State and Hillsborough County officials are working on a taxpayer-funded incentive package aimed at luring the pharmaceutical and consumer goods giant Johnson & Johnson to add upwards of 700 jobs here that would pay an average annual ...
Hillsborough in hunt for up to 700 Johnson & Johnson jobs  Tampabay.com
South Carolina court orders Johnson & Johnson to pay $136 million in Risperdal ...
(Reuters) - South Carolina's Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks.
Johnson & Johnson loses first Risperdal jury trial  Philly.com
Johnson & Johnson Loses Trial Over Risperdal And Male Breasts  Wall Street Journal (blog)
Johnson & Johnson Projects Aim to Spot Who'll Get a Disease
Imagine being able to identify who is likely to develop a particular disease - and then stop the disorder before it starts. That's the goal of three research projects launched by Johnson & Johnson's pharmaceutical research arm, Janssen Research ...
Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price
It seems unlikely that Johnson & Johnson CEO Alex Gorsky would be that "undisciplined" to pay so much for the company, Cramer said on CNBC's "Stop Trading" segment.
Johnson & Johnson Investors Should Welcome The Acquisition Of Pharmacyclics  Seeking Alpha (registration)
Pharmacyclics, Inc. Said To Consider A Sale; Johnson & Johnson, Novartis ...  Bidness ETC
Johnson & Johnson's shared services search comes amid a cost-cutting move
The company is confident it can make that massive cut over three years by taking a fresh look at how it performs support functions, such as IT, finance and human resources, and bringing standardization and commonality across the business systems shared ...
Boston Scientific will pay Johnson & Johnson $600M to end lawsuit over 2006 ...
NEW YORK - Boston Scientific will pay $600 million to settle with drugmaker Johnson & Johnson over the medical device maker's $27 billion acquisition of Guidant Corp.
Johnson & Johnson Loses Risperdal Jury Trial After Young Man Grew 46 DD ...
A Philadelphia jury said Tuesday that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old man with autism from Alabama - who developed size 46 DD breasts as a young teenager - because the company failed to adequately warn of ...
Autistic Man Wins $2.5M In Damages After Antipsychotic Drug Gives Him 46DD ...  Medical Daily
Man Who Grew 46DD Breasts Wins $2.5M Drug Suit  Newser
Boston Scientific settles $7.2B lawsuit brought by Johnson & Johnson for $600M
Johnson & Johnson (NYSE: JNJ) claimed in the lawsuit that Guidant, for which Boston Scientific paid $27 billion, broke the terms of an earlier contract to be acquired by J&J by providing information to BSX.
Boston Scientific settles suit by Johnson & Johnson  Worcester Business Journal
Boston Scientific Corporation (NYSE:BSX) reached a settlement with Johnson ...  Inside Trade
Johnson & Johnson ordered to pay $2.5 million to family of man who grew breasts
After the verdict was reached, a Johnson & Johnson representative insisted that the company had issued adequate warnings about possible side effects in the medication's label and said it was considering an appeal.
Mother brought to tears hearing Johnson & Johnson's Risperdal tactics
Pledger had just finished a full day of listening to her attorney, Thomas Kline, and former U.S. Food and Drug Administration commissioner Dr.
Johnson & Johnson Accused Of Adolescent Risperdal Risks  Bidness ETC